Table 3.
Predictors of re-hospitalizations in single-factor logistic regression
| Categorical variable | With re-hospitalization (%) | Without re-hospitalization (%) | p |
|---|---|---|---|
| leg edema |
91 |
9 |
0.009 |
| hepatomegaly |
88 |
11 |
0.03 |
| No beta-blocker therapy |
98 |
0 |
0.006 |
|
Quantitative variable |
With re-hospitalization (median; Q25–Q75) |
Without re-hospitalization (median; Q25–Q75) |
p |
| BMI 2* |
25; 24–30 |
30; 26–32 |
0.04 |
| NT-proBNP 1 |
1848; 931–3248 |
895; 511–2026 |
0.02 |
| NT-proBNP 2 |
1852; 775–4000 |
745; 360–1680 |
0.005 |
| LVEF 1 |
27; 22–31 |
33; 28–38 |
0.02 |
| LVEF 2 |
30; 24–32 |
34; 29–40 |
0.02 |
| LVsD 2 |
6; 5.2–6.4 |
5.3; 4.4–5.6 |
0.001 |
| MR 1 |
1.5; 1–2 |
1; 0–1 |
0.03 |
| MR 2 |
1; 1–2 |
1; 0–1 |
0.03 |
| 6-MWT 1 |
350; 290–405 |
438; 350–490 |
0.01 |
| 6-MWT 2 | 370; 290–450 | 480; 395–595 | 0.001 |
*1 – for variables assessed after inclusion; 2 – for variables assessed after 2 months.
Q25–Q75: quartiles 25% and 75%.
ABBREVIATIONS:BMI body mass index; NT-proBNP N-terminal pro-brain natriuretic peptide; LVEF left ventricular ejection fraction; LVsD left ventricular systolic diameter; MR mitral regurgitation; 6 MWT 6 minute walk test.